Uncategorized - Page 2 of 6

News October 17, 2023

Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has entered into...

News September 14, 2023

Outcome Capital and YAFO Capital Announce Strategic Partnership to Expand Global Strategic and Financial Services to Biopharma and Healthcare Clients

The collaboration will allow the partners to globally expand financial advisory services and cross-border transactions for life sciences and biopharmaceutical client companies Boston & Shanghai...

News July 20, 2023

Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review

Outcome Capital is Top 10 Life Science Financial Provider for 2023 awarded by Life Science Review July 20, 2023 Read the full article here:

News July 13, 2023

Outcome Capital and Jumpstart Enter into a Corporate Partnership to Support Early Education in Underserved Communities

Collaboration will support early childhood education programs and address early childhood teacher retention. July 13, 2023 08:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a...

News March 08, 2023

As Pandemic Wanes, Firms That Rode C0VID-19 Testing Wave Struggle for Solid Footing

Companies that once rode high on the COVID-19 pandemic may now have to face the possibility of extinction in the coming years.

News January 12, 2023

Public, Private Dx Financing Wanes as Post-Pandemic Diagnostics Landscape Changes

After two years of basking in the spotlight and money flowing into the industry as a result of the COVID-19 pandemic, financing for diagnostics companies has largely withered in 2022.

News December 15, 2022

Outcome Capital Named Top 10 M&A Consulting Firms In 2022

Outcome Capital Named Top 10 M&A Consulting Firms December 1, 2022 Outcome Capital leads in Financial Services Review annual listing of 10 companies that are...

News October 06, 2022

Are SPACs Better Than Traditional IPOs?

Outcome Capital's Managing Director Paul Mieyal, Ph.D., CFA was interviewed by BioSpace for his views on the recent popularity of SPACs in the biotech space. The interview covers historical perspective, current market dynamics, and outlook for the next year.

News August 24, 2022

Investment Banking Firm Outcome Capital Launches Advisory Practice

– Advisory Services Practice to Assist Growth-Stage Life Science Companies in Pre-Transaction Preparation and Strategic Corporate Development – August 24, 2022 08:30 AM Eastern Daylight...

News June 21, 2022

Amid Broader Market Pressures, Dx M&A Deals See Downturn in First Half of 2022

COVID-19 brought significant attention and investment to the diagnostic industry. Coming out of the pandemic new pressures and challenges await. Director Craig Steger shares his views and insights on how firms must be strategic and agile in this new paradigm.

News June 21, 2022

Dx IPOs Plummet, SPAC Market Recedes Among Macroeconomic Difficulties

Managing Director’s Oded Ben-Joseph, PhD, and Paul Mieyal, PhD, were interviewed by 360Dx for their views on capital markets’ current receptiveness towards COVID diagnostics companies and the viability of SPAC’s for life sciences firms.

News May 24, 2022

Outcome Capital Advises ELIOS Vision on Growth Financing Round

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing...

News April 13, 2022

Outcome Capital Advises NanoHive Medical on Growth Financing Round

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that NanoHive Medical, LLC closed on an oversubscribed...

News April 06, 2022

Outcome Capital Announces Innara Health and Cardinal Health Partner to Advance Neonatal Development

BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that Innara Health and Cardinal Health have partnered...

News March 28, 2022

Outcome Capital Expands Its HealthTech and Digital Health Practice with the Addition of Karl Hess as Managing Director

March 28, 2022 10:30 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced...

News March 24, 2022

Outcome Capital Congratulates Dr. Michaele Esdale on Her Invitation to Join the Business Journals Leadership Trust

The Business Journals Leadership Trust announced yesterday that Dr. Michaele Esdale, Vice President of Finance and Operations at Outcome Capital, has joined its exclusive, invitation-only...

News November 12, 2021

Outcome Capital Announces Getinge Has Acquired Verrix

November 12, 2021 10:48 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Outcome Capital, a specialized life sciences and healthcare advisory and investment banking firm, today announced that...

News November 12, 2021

MedTech Money Podcast – Investment Banker’s Insight

Podcast Available At: Spotify Apple Podcasts Google Podcasts Overview: Thomas Busby, Vice President at Outcome Capital, joins host, Giovanni Lauricella, to discuss what an...

News October 05, 2021

Outcome Capital Congratulates Dr. Ellen Baron for the AbCellera Acquisition of TetraGenetics

September 13, 2021 Vancouver, British Columbia & Boston, MA. AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today...

News June 23, 2021

Outcome Capital Advises Nova Technologies in its transaction with Slate Capital Group

June 23, 2021, Reston, VA Outcome Capital, an investment banking firm that serves middle market growth companies in aerospace, defense and government services, technology, and...